Jupiter Asset Management LTD Gilead Sciences, Inc. Transaction History

Jupiter Asset Management LTD

$10.2 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $6.48 Million - $7.9 Million	-90,520 Reduced 92.75%	7,077 $518,000
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $4.04 Million - $4.58 Million	55,112 Added 129.72%	97,597 $7.91 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $2.5 Million - $2.72 Million	33,766 Added 387.27%	42,485 $3.18 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $26.6 Million - $30.4 Million	-350,236 Reduced 97.57%	8,719 $671,000
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $27.8 Million - $31.6 Million	358,955 New	358,955 $29.8 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $183,085 - $229,425	-3,161 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $205,085 - $232,776	3,161 New	3,161 $232,000
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $5.35 Million - $6.1 Million	-89,166 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $1.68 Million - $1.92 Million	29,690 Added 49.92%	89,166 $5.19 Million
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $3.69 Million - $4.64 Million	59,476 New	59,476 $3.76 Million
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $4.89 Million - $5.68 Million	-67,612 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $10.4 Million - $13.3 Million	-166,240 Reduced 71.09%	67,612 $5.05 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $1.08 Million - $1.19 Million	-17,537 Reduced 6.98%	233,852 $15.2 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $500,080 - $552,000	-8,000 Reduced 3.08%	251,389 $15.9 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $970,864 - $1.09 Million	15,692 Added 6.44%	259,389 $17.5 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $293,891 - $329,235	4,700 Added 1.97%	243,697 $15.8 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $1.37 Million - $1.79 Million	22,600 Added 10.44%	238,997 $15 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $2.94 Million - $3.25 Million	41,200 Added 23.52%	216,397 $16.6 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $3.71 Million - $4.53 Million	51,000 Added 41.06%	175,197 $13.2 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $2.6 Million - $3.06 Million	36,597 Added 41.78%	124,197 $8.9 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $6.32 Million - $7.49 Million	87,600	87,600 $7.1 Million

Others Institutions Holding GILD

# of Institutions

1,878

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$9.77 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.46 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.12 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.03 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.

Account